177 related articles for article (PubMed ID: 37864298)
1. PML-mediated nuclear loosening permits immunomodulation of mesenchymal stem/stromal cells under inflammatory conditions.
Chu Y; Jiang Z; Gong Z; Ji X; Zhu M; Shang Q; Gong P; Cao L; Chen Y; Li P; Shao C; Shi Y
Cell Prolif; 2024 Apr; 57(4):e13566. PubMed ID: 37864298
[TBL] [Abstract][Full Text] [Related]
2. The DLC-1 tumor suppressor is involved in regulating immunomodulation of human mesenchymal stromal /stem cells through interacting with the Notch1 protein.
Na T; Zhang K; Yuan BZ
BMC Cancer; 2020 Nov; 20(1):1064. PubMed ID: 33148199
[TBL] [Abstract][Full Text] [Related]
3. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6.
Danchuk S; Ylostalo JH; Hossain F; Sorge R; Ramsey A; Bonvillain RW; Lasky JA; Bunnell BA; Welsh DA; Prockop DJ; Sullivan DE
Stem Cell Res Ther; 2011 May; 2(3):27. PubMed ID: 21569482
[TBL] [Abstract][Full Text] [Related]
4. A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging.
Yu KR; Lee JY; Kim HS; Hong IS; Choi SW; Seo Y; Kang I; Kim JJ; Lee BC; Lee S; Kurtz A; Seo KW; Kang KS
PLoS One; 2014; 9(8):e102426. PubMed ID: 25090227
[TBL] [Abstract][Full Text] [Related]
5.
Jeske R; Yuan X; Fu Q; Bunnell BA; Logan TM; Li Y
Front Immunol; 2021; 12():621744. PubMed ID: 33777002
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Methicillin-resistant Staphylococcus aureus-induced cytokines mRNA production in human bone marrow derived mesenchymal stem cells by 1,25-dihydroxyvitamin D3.
Maiti A; Jiranek WA
BMC Cell Biol; 2014 Mar; 15():11. PubMed ID: 24661536
[TBL] [Abstract][Full Text] [Related]
7. The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells.
Fu S; Wei J; Wang G; Wang B; Wang Y; Lai X; Huang H
Int J Oncol; 2015 Jan; 46(1):351-9. PubMed ID: 25354534
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization.
Corpet A; Olbrich T; Gwerder M; Fink D; Stucki M
Cell Cycle; 2014; 13(2):249-67. PubMed ID: 24200965
[TBL] [Abstract][Full Text] [Related]
9. PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells.
Sun J; Fu S; Zhong W; Huang H
Oncol Rep; 2013 Dec; 30(6):2785-94. PubMed ID: 24101171
[TBL] [Abstract][Full Text] [Related]
10. ZKSCAN3 counteracts cellular senescence by stabilizing heterochromatin.
Hu H; Ji Q; Song M; Ren J; Liu Z; Wang Z; Liu X; Yan K; Hu J; Jing Y; Wang S; Zhang W; Liu GH; Qu J
Nucleic Acids Res; 2020 Jun; 48(11):6001-6018. PubMed ID: 32427330
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses.
Tomchuck SL; Zwezdaryk KJ; Coffelt SB; Waterman RS; Danka ES; Scandurro AB
Stem Cells; 2008 Jan; 26(1):99-107. PubMed ID: 17916800
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone priming enhances stemness and immunomodulatory property of tissue-specific human mesenchymal stem cells.
Rawat S; Dadhwal V; Mohanty S
BMC Dev Biol; 2021 Nov; 21(1):16. PubMed ID: 34736395
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokines and ARDS pulmonary edema fluid induce CD40 on human mesenchymal stromal cells-A potential mechanism for immune modulation.
Wilfong EM; Croze R; Fang X; Schwede M; Niemi E; López GY; Lee JW; Nakamura MC; Matthay MA
PLoS One; 2020; 15(10):e0240319. PubMed ID: 33021986
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ-tethered hydrogels enhance mesenchymal stem cell-based immunomodulation and promote tissue repair.
García JR; Quirós M; Han WM; O'Leary MN; Cox GN; Nusrat A; García AJ
Biomaterials; 2019 Nov; 220():119403. PubMed ID: 31401468
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients.
Kim KW; Kim HJ; Kim BM; Kwon YR; Kim HR; Kim YJ
Stem Cell Res Ther; 2018 Aug; 9(1):208. PubMed ID: 30092847
[TBL] [Abstract][Full Text] [Related]
16. The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the
Leyendecker A; Pinheiro CCG; Amano MT; Bueno DF
Front Immunol; 2018; 9():2056. PubMed ID: 30254638
[No Abstract] [Full Text] [Related]
17. Inflammatory Licensed hMSCs Exhibit Enhanced Immunomodulatory Capacity in a Biomaterial Mediated Manner.
Kolliopoulos V; Polanek M; Xu H; Harley B
ACS Biomater Sci Eng; 2023 Aug; 9(8):4916-4928. PubMed ID: 37390452
[TBL] [Abstract][Full Text] [Related]
18. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
19. Cytokines Differently Define the Immunomodulation of Mesenchymal Stem Cells from the Periodontal Ligament.
Behm C; Blufstein A; Gahn J; Nemec M; Moritz A; Rausch-Fan X; Andrukhov O
Cells; 2020 May; 9(5):. PubMed ID: 32423044
[TBL] [Abstract][Full Text] [Related]
20. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
